PF-07260437
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07260437, covering 2025-05-06 to 2025-05-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of PF-07260437 in Advanced or Metastatic Solid Tumors [Phase 1]